<DOC>
	<DOCNO>NCT02968628</DOCNO>
	<brief_summary>Alterations intrauterine environment profound effect fetal development . Diabetes gestation result multiple deleterious short-term outcome difference , correlate long-term developmental deficit . Multiple study , neonates school-aged child , demonstrate difference language , attention psychomotor development offspring diabetic pregnancy . Neonatal EEG promise non-invasive tool assessment abnormal brain development `` dysmaturity '' population . Multiple conventional EEG ( cEEG ) amplitude-integrated EEG ( aEEG ) parameter change predictably advance gestational development use differentiate risk group neonatal study . The investigator hypothesize neonatal EEG identify brain dysmaturity infant diabetic mother ( IDMs ) compare gestational-age matched control . The primary aim documentation brain dysmaturity IDMs use cEEG . The secondary aim establishment aEEG accessible tool quantify effect maternal diabetes neonatal brain development . The investigator conduct pilot study compare cEEG aEEG parameter case gestational-age match control . Cases IDM neonates least 35 week ' gestation whose mother recommend treatment either insulin oral glycemic agent . Video EEG record plan approximately 60 minute obtain 24 hour 5 day life birth hospitalization . Additional data extract maternal neonatal medical record maternal questionnaire . In addition evaluate measure cEEG aEEG , project establish research cohort . A subsequent study involve developmental evaluation allow correlation EEG result long-term outcome . The ability identify risk birth would provide opportunity intervene order mitigate outcome difference , particularly language development . More significantly , hope establish neonatal CNS outcome measure future diabetic pregnancy intervention study . .</brief_summary>
	<brief_title>Effect Maternal Diabetes Brain Development , Measured Neonatal Electroencephalogram ( EEG )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Infant , Newborn , Diseases</mesh_term>
	<mesh_term>Pregnancy Diabetics</mesh_term>
	<criteria>&gt; /= 35 week postmenstrual age delivery Dating , consistent , 1st trimester ultrasound Mother able communicate oral write English Available maternal obstetric record medication history Singleton gestation Delivery URMC attend obstetric staff Maternal Diagnosis obstetrician intrauterine growth restriction ( IUGR ) Documentation medical record daily maternal cigarette smoke 2nd 3rd trimester Chronic maternal sedative opiate use ( &gt; weekly use ) Recreational opiate use addiction Cocaine amphetamine use pregnancy ETOH abuse concern abuse pregnancy ( &gt; weekly use ) Other maternal condition may compromise fetus Psychiatric medication beyond isolated SSRI use Antiepileptic drug ( AEDs ) gestation Magnesium exposure within 3 day delivery Neonatal Blood gas pH less 7.1 , obtain ( cord prior EEG ) Apgar le 8 5 min CNS malformation , seizure , subgaleal intracranial bleeds Cardiac anomaly except asymptomatic smallmoderate VSD , ASD , PDA Clinically significant malformation chromosomal anomaly Smallforgestational age ( &lt; 10th % Fenton growth curve ) Respiratory distress ever require intubation require CPAP support &gt; 48 hour Hemodynamic instability require use pressor &gt; 2 bolus Culture positive sepsis Clinical concern meningitis encephalopathy Sedation medication conditions/medications affect CNS function Clinically obtain total bilirubin 15 day EEG Scalp injury prevent placement EEG lead Pointofcare test ( POCT ) glucose &lt; 45 time EEG</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Hours</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>